245 related articles for article (PubMed ID: 9083271)
1. Role of T cells in the mediation of Heymann nephritis. ii. Identification of Th1 and cytotoxic cells in glomeruli.
Penny MJ; Boyd RA; Hall BM
Kidney Int; 1997 Apr; 51(4):1059-68. PubMed ID: 9083271
[TBL] [Abstract][Full Text] [Related]
2. Permanent CD8(+) T cell depletion prevents proteinuria in active Heymann nephritis.
Penny MJ; Boyd RA; Hall BM
J Exp Med; 1998 Nov; 188(10):1775-84. PubMed ID: 9815255
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition.
Penny MJ; Boyd RA; Hall BM
J Am Soc Nephrol; 1998 Dec; 9(12):2272-82. PubMed ID: 9848781
[TBL] [Abstract][Full Text] [Related]
4. Il-4 therapy prevents the development of proteinuria in active Heymann nephritis by inhibition of Tc1 cells.
Spicer ST; Ha H; Boyd RA; He XY; Carter N; Tran G; Penny MJ; Hodgkinson SJ; Hall BM
J Immunol; 2001 Oct; 167(7):3725-33. PubMed ID: 11564788
[TBL] [Abstract][Full Text] [Related]
5. The role of T cells in the mediation of glomerular injury in Heymann's nephritis in the rat.
Quiza CG; Leenaerts PL; Hall BM
Int Immunol; 1992 Apr; 4(4):423-32. PubMed ID: 1591215
[TBL] [Abstract][Full Text] [Related]
6. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats.
Spicer ST; Tran GT; Killingsworth MC; Carter N; Power DA; Paizis K; Boyd R; Hodgkinson SJ; Hall BM
J Immunol; 2007 Jul; 179(1):172-8. PubMed ID: 17579035
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccination against specific pathogenic TCRs reduces proteinuria in active Heymann nephritis by inducing specific autoantibodies.
Wu H; Walters G; Knight JF; Alexander SI
J Immunol; 2003 Nov; 171(9):4824-9. PubMed ID: 14568961
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis.
Schiller B; He C; Salant DJ; Lim A; Alexander JJ; Quigg RJ
J Exp Med; 1998 Oct; 188(7):1353-8. PubMed ID: 9763614
[TBL] [Abstract][Full Text] [Related]
9. An anti-CD5 monoclonal antibody ameliorates proteinuria and glomerular lesions in rat mesangioproliferative glomerulonephritis.
Ikezumi Y; Kawachi H; Toyabe S; Uchiyama M; Shimizu F
Kidney Int; 2000 Jul; 58(1):100-14. PubMed ID: 10886554
[TBL] [Abstract][Full Text] [Related]
10. Heymann nephritis in Lewis rats.
Wang YM; Lee VWS; Wu H; Harris DCH; Alexander SI
Curr Protoc Immunol; 2015 Apr; 109():15.29.1-15.29.6. PubMed ID: 25845564
[TBL] [Abstract][Full Text] [Related]
11. The role of lymphocytes in the experimental progressive glomerulonephritis.
Ikezumi Y; Kanno K; Karasawa T; Han GD; Ito Y; Koike H; Toyabe S; Uchiyama M; Shimizu F; Kawachi H
Kidney Int; 2004 Sep; 66(3):1036-48. PubMed ID: 15327397
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats.
Huang XR; Tipping PG; Apostolopoulos J; Oettinger C; D'Souza M; Milton G; Holdsworth SR
Clin Exp Immunol; 1997 Jul; 109(1):134-42. PubMed ID: 9218836
[TBL] [Abstract][Full Text] [Related]
13. T cell lines specific for a synthetic Heymann nephritis peptide derived from the receptor-associated protein.
Wu H; Zhang GY; Knight JF
Clin Exp Immunol; 2000 Jul; 121(1):157-64. PubMed ID: 10886254
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ-producing effector CD8 T lymphocytes cause immune glomerular injury by recognizing antigen presented as immune complex on target tissue.
Tsumiyama K; Hashiramoto A; Takimoto M; Tsuji-Kawahara S; Miyazawa M; Shiozawa S
J Immunol; 2013 Jul; 191(1):91-6. PubMed ID: 23720810
[TBL] [Abstract][Full Text] [Related]
15. Glomerular T cells in Heymann nephritis.
Walters G; Wu H; Knight JF
Clin Exp Immunol; 2001 Nov; 126(2):319-25. PubMed ID: 11703377
[TBL] [Abstract][Full Text] [Related]
16. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
[TBL] [Abstract][Full Text] [Related]
17. Th2 responses induce humorally mediated injury in experimental anti-glomerular basement membrane glomerulonephritis.
Huang XR; Holdsworth SR; Tipping PG
J Am Soc Nephrol; 1997 Jul; 8(7):1101-8. PubMed ID: 9219159
[TBL] [Abstract][Full Text] [Related]
18. Immunologic determinants of susceptibility to experimental glomerulonephritis: role of cellular immunity.
Coelho SN; Saleem S; Konieczny BT; Parekh KR; Baddoura FK; Lakkis FG
Kidney Int; 1997 Mar; 51(3):646-52. PubMed ID: 9067895
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental membranous glomerulonephritis in rats by an anti-MHC class II antibody.
Hasegawa Y; Kaneoka H; Tanaka T; Ogahara S; Matsumae T; Noda R; Yoshitake K; Murata T; Naito S
Nephron; 2001 Jul; 88(3):233-40. PubMed ID: 11423754
[TBL] [Abstract][Full Text] [Related]
20. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.
Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL
Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
